Patienter, der fik profylaktisk behandling med micafungin, var de, som gennemgik en hæmatopoetisk stamcelletransplantation (HSCT), og som havde en høj risiko for at få svampeinfektion.
Patients treated prophylactically with micafungin were those undergoing haematopoetic stem cell transplantation (HSCT) who were at high risk for fungal infections.